
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
Author(s) -
J.B. Buse,
A.L. Carlson,
M. Komatsu,
O. Mosenzon,
L. Rose,
B. Liang,
K. Buchholtz,
H. Horio,
T. Kadowaki
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/bbtv-d113
Subject(s) - insulin aspart , insulin degludec , medicine , double blind , insulin , type 2 diabetes , diabetes mellitus , endocrinology , randomized controlled trial , insulin glargine , alternative medicine , placebo , pathology